Shared genetic architecture highlights the bidirectional association between major depressive disorder and fracture risk

Abstract

The genetic pleiotropy between MDD and fracture highlights the bidirectional association observed in the epidemiological analysis. The shared genetic components (such as <i>SGIP1</i>) between the diseases suggest that modulating the endocannabinoid system could be a potential therapeutic strategy for both MDD and bone loss.